CN102716251B - Externally dressed drug for treating femoral head necrosis - Google Patents

Externally dressed drug for treating femoral head necrosis Download PDF

Info

Publication number
CN102716251B
CN102716251B CN201110165067.7A CN201110165067A CN102716251B CN 102716251 B CN102716251 B CN 102716251B CN 201110165067 A CN201110165067 A CN 201110165067A CN 102716251 B CN102716251 B CN 102716251B
Authority
CN
China
Prior art keywords
grams
head necrosis
drug
treatment
femoral head
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201110165067.7A
Other languages
Chinese (zh)
Other versions
CN102716251A (en
Inventor
王长锋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201110165067.7A priority Critical patent/CN102716251B/en
Publication of CN102716251A publication Critical patent/CN102716251A/en
Application granted granted Critical
Publication of CN102716251B publication Critical patent/CN102716251B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention, relating to the field of traditional Chinese medicine, discloses an externally dressed drug for treating femoral head necrosis, solving the problems of slow effect of treatment, patients in pain for a long time and the like existing in the prior art. The drug comprises the following ingredients: 20-25g of olibanum, 20-25g of myrrh, 20-25g of radix rehmanniae preparata, 5-8 g of cinnabar, 20-30g of Panax notoginseng powder, 30-35g of safflower, 10-15g of pillis ophidiae, 5-10g of Eupolyphaga Steleophaga, and 15-20g of Angelica sinensis. By using the drug of the invention, quick effect can be achieved, patients can be healed in 15-20 days, the femoral head necrosis patients are completely cured without recurrence, there is no side effect, and the ability to walk can be regained. After curing, there is no sequela.

Description

The topical agent for the treatment of femur head necrosis
Technical field:
The present invention relates to the field of Chinese medicines, be specially a kind of topical agent for the treatment of femur head necrosis.
Background technology:
Hip joint, is one of human body six large joints, is that mankind's repeating motion is maximum, and femoral head carries maximum joint.Generally traditional medical science viewpoint is thought, bone necrosis, particularly femur head necrosis can not repair, and are irreversible.Conventional Therapeutic Method is operation, not only has a big risk, medical expense is high, and can bring great misery to patient, and postoperative recovery is more difficult.Artificial femoral head replacement's infectious-related complication is difficult to overcome, and occur to infect, loosening, joint stiffness, pain etc., can cause patient's lifelong disability.
At present, the prescription for the treatment of femur head necrosis is a lot, but all has shortcomings:
1, curative effect is poor;
2, ineffective;
3, effect is undesirable, and patient's time that groans is long;
4, expense is huge.
Facts have proved, motherland's medicine and pharmacology are accumulating rich experience aspect treatment femur head necrosis, and the traditional Chinese medical science is more emphasized whole treatment, and treating both the principal and secondary aspects of a disease puts prevention first, and Chinese medicine is few and famous with untoward reaction.Therefore, this sick Chinese medicine preparation of development treatment is highly significant with necessity.
Summary of the invention:
The object of the present invention is to provide a kind of topical agent for the treatment of femur head necrosis, solve responding well to treatment slowly of existing in prior art, patient is subject to the problems such as ailing time length.
To achieve these goals, the present invention adopts following technical scheme to be:
A topical agent for the treatment of femur head necrosis, medicament consists of: 20~25 grams of Olibanums, 20~25 grams of Myrrhas, 20~25 grams, Radix Rehmanniae Preparata, 5~8 grams, Cinnabaris, 20~30 grams of Radix Notoginseng powder, 30~35 grams, Flos Carthami, 10~15 grams of Periostracum Serpentiss, 5~10 grams of Eupolyphaga Seu Steleophagas, 15~20 grams of Radix Angelicae Sinensis.
The topical agent of described treatment femur head necrosis, medicament composition is preferably: 22 grams of Olibanums, 22 grams of Myrrhas, 22 grams, Radix Rehmanniae Preparata, 6 grams, Cinnabaris, 25 grams of Radix Notoginseng powder, 32 grams, Flos Carthami, 12 grams of Periostracum Serpentiss, 8 grams of Eupolyphaga Seu Steleophagas, 18 grams of Radix Angelicae Sinensis.
The topical agent of described treatment femur head necrosis, medicament is Powdered, and Radix Notoginseng powder is powdery, and granularity is 80~150 orders, and the granularity of all the other powder is 8~12 orders.
The topical agent of described treatment femur head necrosis, every secondary topical agent is got 150~200 grams.Medicament before use, is poured medicament in vinegar into and is stirred, and vinegar and medicament part by weight are 50:(150~200); Then with gauze parcel, pave rear use, during use, spread on wound; During external application, medicine layer thickness is 0.8~1.2 centimetre, covers whole ill hip joint extension more than 5 centimetres.
Pharmacology analysis of the present invention is as follows:
(1) Olibanum, controls coagulation of QI-blood, trusted subordinate's pain, carbuncle pyogenic infections from tumour or sore, traumatic injury.Olibanum compatibility Myrrha: the two all has the merit of promoting blood circulation to remove blood stasis pain relieving, detumescence and promoting granulation.
The pungent Wen Xiangrun of Olibanum, the gas in energy promoting the circulation of blood, pain relieving power is strong, the energy relaxing muscles and tendons and activating QI and blood in the collateral of holding concurrently; The arduous property of Myrrha is flat, is longer than the loose blood of blood stasis expelling, and the broken power of letting out is large, and Olibanum, Myrrha 5 be use mutually, and its effect is more remarkable, the effect of playing altogether promoting blood circulation to remove obstruction in the collateral, reducing swelling and alleviating pain, expelling pus and promoting granulation, and external application is used for the treatment of that skin infection is not routedly held back for a long time, the muscle of traumatic injury swells and ache.
Olibanum compatibility Flos Carthami: Olibanum promoting blood circulation and stopping pain detumescence, Flos Carthami activating blood and removing stasis, Papillary, has the effect of activating blood and removing stasis pain relieving, and the congestion that is used for the treatment of traumatic injury swells and ache.
(2) Myrrha, has the effects such as promoting blood circulation and stopping pain, detumescence and promoting granulation, cures mainly traumatic injury, bones and muscles pain; Prevent that tissue deterioration from producing effect very much, especially have the situation of wound gangrene.Its refrigerant function can help corridor, skin ulcer and skin ulcer, can also improve the stream wound of soup and the skin of be full of cracks.
Myrrha compatibility Flos Carthami, Myrrha promoting blood circulation and stopping pain, Flos Carthami activating blood and removing stasis stimulates the menstrual flow, and Papillary has the silt of invigorating blood circulation, dispel, stimulates the menstrual flow, the effect of pain relieving, by the stasis pain of become silted up in trusted subordinate's pain, dysmenorrhea, puerperal due to what treatment blood stasis resistance stomachache and traumatic injury.
(3) Radix Rehmanniae Preparata, the YIN nourishing of enriching blood, vital essence replenishing and marrow benifiting, bone and muscle strengthening, can promote the recovery of anemia animal erythrocyte, hemoglobin, accelerates the propagation of pluripotential hemopoietic stem cell (CFU-S), bone marrow hemopoietic progenitor cell of red blood cell line (CFU-E).
(4) Cinnabaris, clears away heart-fire relieving convulsion, and the removing toxic substances of calming the nerves, has calmness, syngignoscism.According to < <, not recording > > records: promoting blood circulation, and stop stuffy sensation with restlessness, quench one's thirst, benefit spirit, moistening face color, except attacked by pestiferous factors stomachache, all skin ulcers of poison scabies flaccidity.
(5) Radix Notoginseng powder, regulates the flow of vital energy, and astringent therapy cures mainly detumescence, traumatic injury, congestion and swelling pain, sufferings etc., and Radix Notoginseng has the title of " refreshing medicine stops blooding ", dissipating blood stasis blood, and hemostasis and do not stay the stasis of blood, to have the stagnant person of the stasis of blood concurrently more suitable to hemorrhage.Radix Notoginseng has promoting blood circulation to remove blood stasis effect, energy antiplatelet aggregation, and antithrombotic forms.
(6) Flos Carthami, promoting blood circulation to restore menstrual flow, blood stasis removing pain relieving, applicable various varicosis, peripheral neuritis, blood circulation is bad, lower limb numbness or the congestion such as livid purple; Flos Carthami can make whole blood clotting time and blood plasma (ischemia platelet) recalcification time significant prolongation.From Flos Carthami, isolated effective ingredient Carthamus yellow, has inhibition platelet aggregation, increases fibrinoclase active, suppresses the effects such as external thrombus formation.
(7) Periostracum Serpentis, has and dispels the wind, arresting convulsion, and removing toxic substances, the effect of nebula removing, containing ossein, can treat osteodynia.
(8) Eupolyphaga Seu Steleophaga, has removing blood stasis, removing mass, dredging collateral, reason wound and reunion of bone, reducing swelling and alleviating pain, the stimulating milk secretion effect such as stimulate the menstrual flow, and is treating blood disorders traumatology key medicine, for injured bone.
(9) Radix Angelicae Sinensis, the effect of invigorating blood circulation of enriching blood, cures mainly rheumatic arthralgia, injury from falling down etc., and Radix Angelicae Sinensis is always by the traditional Chinese medical science key medicine that is considered as enriching blood, for the treatment of anemia.Can anticoagulant, antithrombotic, and have extremely significant hematosis.
Beneficial effect of the present invention:
1, instant effect, can fully recover in 15~20 days;
2, cure thoroughly, no longer recurrence;
3, without any side effect;
4, recover walking function;
5, after curing, without any sequela.
The specific embodiment:
Embodiment 1
In the present embodiment, the consisting of of medicament: 22 grams of Olibanums, 22 grams of Myrrhas, 22 grams, Radix Rehmanniae Preparata, 6 grams, Cinnabaris, 25 grams of Radix Notoginseng powder, 32 grams, Flos Carthami, 12 grams of Periostracum Serpentiss, 8 grams of Eupolyphaga Seu Steleophagas, 18 grams of Radix Angelicae Sinensis.Medicament before use, will stir in the medicament vinegar that to pour into by vinegar and medicament part by weight be 50:180, then with gauze parcel, paves rear use, spreads on wound during use; During external application, medicine layer thickness is 0.8~1.2 centimetre, covers whole ill hip joint extension more than 5 centimetres.
Clinic Case:
Revive so-and-so, man, 38 years old, rural area, Beizhen City tiler; In rural area, build a house throughout the year, almost drink every day, obtained in the course of time femoral head necrosis, seek medical advice and medicine everywhere, almost go bankrupt or broke; In " a gang of one " activity, Department of Office Affairs deputy bureau director in Liaoning Province comes to his home, sees and having nothing but the bare walls in the house, and this person liied in bed at that time and can not walk, agonizing.This deputy bureau director recommends and uses the embodiment of the present invention 1 topical agent treatment, thigh root heating with the sensation of beating after 3 days, and every couple of days sprays a vinegar to medicated bag, within every 7 days, changes medicated bag No. one time, and coordinates limb activity, after 15 days, can descend and go slowly; Through two wheat harvesting periods, the treatment of 7 pairs of medicated bags, thoroughly recovery from illness, can restart again work, so far not recurrence.
Embodiment 2
In the present embodiment, the consisting of of medicament: 20 grams of Olibanums, 25 grams of Myrrhas, 20 grams, Radix Rehmanniae Preparata, 8 grams, Cinnabaris, 20 grams of Radix Notoginseng powder, 35 grams, Flos Carthami, 10 grams of Periostracum Serpentiss, 10 grams of Eupolyphaga Seu Steleophagas, 15 grams of Radix Angelicae Sinensis.
Medicament before use, will stir in the medicament vinegar that to pour into by vinegar and medicament part by weight be 50:150, then with gauze parcel, paves rear use, spreads on wound during use; During external application, medicine layer thickness is 0.8~1.2 centimetre, covers whole ill hip joint extension more than 5 centimetres.
Embodiment 3
In the present embodiment, the consisting of of medicament: 25 grams of Olibanums, 20 grams of Myrrhas, 25 grams, Radix Rehmanniae Preparata, 5 grams, Cinnabaris, 30 grams of Radix Notoginseng powder, 30 grams, Flos Carthami, 15 grams of Periostracum Serpentiss, 5 grams of Eupolyphaga Seu Steleophagas, 20 grams of Radix Angelicae Sinensis.
Medicament before use, will stir in the medicament vinegar that to pour into by vinegar and medicament part by weight be 50:200, then with gauze parcel, paves rear use, spreads on wound during use; During external application, medicine layer thickness is 0.8~1.2 centimetre, covers whole ill hip joint extension more than 5 centimetres.

Claims (3)

1. a topical agent for the treatment of femur head necrosis, it is characterized in that, medicament consists of: 20~25 grams of Olibanums, 20~25 grams of Myrrhas, 20~25 grams, Radix Rehmanniae Preparata, 5~8 grams, Cinnabaris, 20~30 grams of Radix Notoginseng powder, 30~35 grams, Flos Carthami, 10~15 grams of Periostracum Serpentiss, 5~10 grams of Eupolyphaga Seu Steleophagas, 15~20 grams of Radix Angelicae Sinensis.
2. according to the topical agent for the treatment of femur head necrosis claimed in claim 1, it is characterized in that, medicament composition is preferably: 22 grams of Olibanums, 22 grams of Myrrhas, 22 grams, Radix Rehmanniae Preparata, 6 grams, Cinnabaris, 25 grams of Radix Notoginseng powder, 32 grams, Flos Carthami, 12 grams of Periostracum Serpentiss, 8 grams of Eupolyphaga Seu Steleophagas, 18 grams of Radix Angelicae Sinensis.
3. according to the topical agent for the treatment of femur head necrosis claimed in claim 1, it is characterized in that, medicament is Powdered, and Radix Notoginseng powder is powdery, and granularity is 80~150 orders, and the granularity of all the other powder is 8~12 orders.
CN201110165067.7A 2011-06-20 2011-06-20 Externally dressed drug for treating femoral head necrosis Expired - Fee Related CN102716251B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201110165067.7A CN102716251B (en) 2011-06-20 2011-06-20 Externally dressed drug for treating femoral head necrosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201110165067.7A CN102716251B (en) 2011-06-20 2011-06-20 Externally dressed drug for treating femoral head necrosis

Publications (2)

Publication Number Publication Date
CN102716251A CN102716251A (en) 2012-10-10
CN102716251B true CN102716251B (en) 2014-10-08

Family

ID=46942205

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201110165067.7A Expired - Fee Related CN102716251B (en) 2011-06-20 2011-06-20 Externally dressed drug for treating femoral head necrosis

Country Status (1)

Country Link
CN (1) CN102716251B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101088527A (en) * 2006-06-14 2007-12-19 宫恩年 Medicine composition for treating bone necrosis and its prepn process

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101088527A (en) * 2006-06-14 2007-12-19 宫恩年 Medicine composition for treating bone necrosis and its prepn process

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
陈晓明.综合疗法治疗股骨头缺血性坏死症26例.《河北中医》.1998,(第03期), *

Also Published As

Publication number Publication date
CN102716251A (en) 2012-10-10

Similar Documents

Publication Publication Date Title
CN104288538A (en) Plaster for treating neck, shoulder, waist and leg diseases and preparation method of plaster
CN105267389A (en) External medicine for activating blood circulation and reducing swelling
CN1322885C (en) Plaster medicine composition with multiple purpose for treating affection pain due to dampness
CN107184782A (en) External medicine composition, preparation method and applications
CN101732522B (en) Plaster for treating osteonecrosis of the femoral head, osseous tuberculosis, osteomyelitis and osteoma
CN108210691A (en) A kind of plaster for treating fracture wound and preparation method thereof
CN102274474A (en) Medicinal liquor for treating rheumatic diseases
CN102755622A (en) Medicine for treating rheumatoid arthritis
CN102716251B (en) Externally dressed drug for treating femoral head necrosis
CN110538272A (en) swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof
CN103223078A (en) Traditional Chinese medicine used for treating knee osteoarthritis through iontophoresis
CN103417788B (en) One treats fracture Chinese medicine for oral administration
CN102716239A (en) Pharmaceutical composite for treating traumatic injury
CN101708324B (en) Plaster used for treating femoral head necrosis and preparation method thereof
CN109966451A (en) A kind of Chinese medicine composition of bone-setting and pain-relieving
CN103520415A (en) Medicament for treating traumatic injuries
CN104225119A (en) Powder for treating back pain
CN103961434B (en) A kind of fracture surgery Chinese medicine composition
CN103463348A (en) Osteopathic pain relieving ointment
CN102716389B (en) Externally dressed drug for treating gout
CN101757223B (en) Externally-applied traditional Chinese medicine for treating psoriasis
CN105816603A (en) Traditional Chinese medicine composition for treating postpartum hemorrhage
CN106421410A (en) Traditional Chinese medicine composition for treating diabetic foot
CN104587394A (en) Traditional Chinese medicine composition for treating delayed union and nonunion
CN105617214A (en) Traditional Chinese medicine composition for treating scabies

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20141008

Termination date: 20180620

CF01 Termination of patent right due to non-payment of annual fee